155 related articles for article (PubMed ID: 38419239)
21. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
[TBL] [Abstract][Full Text] [Related]
22. Evolution tumour models paving the way for understanding oral carcinogenesis.
Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
[TBL] [Abstract][Full Text] [Related]
23. Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
Bastías D; Maturana A; Marín C; Martínez R; Niklander SE
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473882
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.
Elhendawy HA
Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988
[TBL] [Abstract][Full Text] [Related]
25. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
26. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
[TBL] [Abstract][Full Text] [Related]
27. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma.
Kouketsu A; Haruka S; Kuroda K; Hitoshi M; Kensuke Y; Tsuyoshi S; Takahashi T; Hiroyuki K
J Oral Pathol Med; 2023 Jan; 52(1):9-19. PubMed ID: 36380437
[TBL] [Abstract][Full Text] [Related]
28. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
29. Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study).
Abdelwhab A; Shaker O; Aggour RL
Oral Dis; 2023 May; 29(4):1487-1494. PubMed ID: 35080082
[TBL] [Abstract][Full Text] [Related]
30. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
31. Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review.
Wang S; Yang M; Li R; Bai J
Eur J Med Res; 2023 Jan; 28(1):53. PubMed ID: 36707844
[TBL] [Abstract][Full Text] [Related]
32. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis.
Bugshan A; Farooq I
F1000Res; 2020; 9():229. PubMed ID: 32399208
[TBL] [Abstract][Full Text] [Related]
33. The implications of nanodiagnostics and artificial intelligence for detecting oral potentially malignant disorders and oral squamous cell carcinoma.
Liu W; Wang Y; Yang X; Shen X; Shi L
Int J Surg; 2023 Oct; 109(10):3248-3250. PubMed ID: 37352524
[No Abstract] [Full Text] [Related]
34. Oral squamous cell carcinoma arising from chronic traumatic ulcers.
Gilligan G; Piemonte E; Lazos J; Simancas MC; Panico R; Warnakulasuriya S
Clin Oral Investig; 2023 Jan; 27(1):193-201. PubMed ID: 36088397
[TBL] [Abstract][Full Text] [Related]
35. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
36. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
37. High-Risk Human Papillomavirus in Patients with Oral Carcinoma and Oral Potentially Malignant Disorders in Serbia-A Pilot Study.
Petrović A; Čanković M; Avramov M; Popović ŽD; Janković S; Mojsilović S
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893561
[No Abstract] [Full Text] [Related]
38. Consensus guidelines on management of oral potentially malignant disorders.
Birur PN; Patrick S; Warnakulasuriya S; Gurushanth K; Raghavan SA; Rath GK; Chaturvedi P; Chandru V; Mathew B; Prabhash K; Gurudath S; Mukhia N; Sunny SP; Mehrotra R; Vivek V; Patil S; Kumar GS; Fasalkar S; Pratima R; Kuriakose MA
Indian J Cancer; 2022; 59(3):442-453. PubMed ID: 36412324
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis.
Min A; Zhu C; Peng S; Rajthala S; Costea DE; Sapkota D
Biomed Res Int; 2015; 2015():186904. PubMed ID: 26504785
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
Walsh T; Macey R; Kerr AR; Lingen MW; Ogden GR; Warnakulasuriya S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010276. PubMed ID: 34282854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
